logo
I spent $10K on a nose job...and woke up with part of my face missing

I spent $10K on a nose job...and woke up with part of my face missing

Daily Mail​3 days ago
EXCLUSIVE I spent $10K on a nose job...and woke up with part of my face missing
READ MORE: Woman reveals horrifying nose after plastic surgery goes wrong
A mother-of-four has been left looking 'smashed' and struggling to breathe after a $10,000 nose job.
Ashley Caselli, now 37, underwent a revision rhinoplasty, or nose job, with Dr. Lindsay Sturm in January 2021, in the hopes of resolving her breathing issues.
But when she woke up from the around three-hour procedure, the Iowa native says she was immediately plunged into a world of constant worries about her new nose.
'It just looked smashed,' she told DailyMail.com. 'It doesn't look finished. It looks like I am missing a piece of my face; My nose doesn't even have a tip anymore.'
Once a social mom who loved taking pictures of herself with her children, Caselli is now consumed by fear whenever she leaves the house and is always photoshopping herself in family pictures.
She also said her breathing is now 'much worse', and that she wakes up several times every night with a dry mouth and has to pull up her nose when she runs to get air in.
She said: 'It's just no way to live. It really hurts your self-confidence; it hurts your way of thinking whenever you do things and want to take pictures with your family.
'Every day, I look in the mirror and I am saddened by it, and when people look at me, I constantly wonder, are they looking at my nose?'
Ashley Caselli pictured before the procedure
And afterward. She said her nose now appears 'smashed'
Caselli is one of at least eight patients to have come forward in recent months alleging harm by Sturm, who ran a clinic in Iowa until February this year.
The cosmetic surgeon and otolaryngologist, a surgeon specializing in the ears, nose, throat, neck and head, has also been accused of causing the death of her patient Angela Kettwig in a lawsuit, although she denies the allegation. The lawsuit is pending.
Others to come forward include Christine Heintz, who paid Sturm $20,000 for a 'mommy makeover' in November 2021, which included a breast reduction and lift, abdominoplasty and liposuction.
Just after the surgery, she said that a 'giant hole' opened in Heintz's right breast going back to her ribcage, with doctors saying most of the breast had died and could not be saved.
She underwent further reconstructive surgery in January 2023 which resulted in her losing most of her breasts.
In another case, patient AJ Gomez-Han visited Sturm in 2024 for skin removal surgery to his thighs and arms.
Afterward, he developed a bacterial infection that evolved into an open bleeding sore and required six weeks in the hospital to fix.
Sturm has not responded to previous claims against her and did not respond to DailyMail.com's request for comment on Caselli's case.
Caselli has not filed a lawsuit, however, because the procedure happened too long ago for her to file a claim under Iowa law.
After her clinic, Sturm Cosmetic Surgery, abruptly closed on February 9, it told patients in an email that 'due to personal, emergent medical concerns, Dr Sturm is unavailable to provide ongoing care.'
Caselli is pictured above in the profile view before the procedure
And again after the procedure
Her nose shown above from the underside before the procedure
And again after the procedure
The Iowa Board of Medicine charged her with professional incompetence, including failure of a physician to exercise a degree of care ordinarily exercised by the average physician, in May 2025.
Sturm opted not to contest the charges and has voluntarily surrendered her license, without admitting wrongdoing. She also filed for bankruptcy in June, according to local media reports.
In Caselli's case, the mother and property manager went for her first nose job with a different surgeon in 2018 to open up her airways and resolve a long-term breathing issue.
The initial procedure 'wasn't terrible,' she said, but she was still having trouble breathing out of one side of her nose and felt one side also appeared 'cuppier' than the other.
This led her to contact Sturm, who said she would be able to help Caselli breathe better and have a more appealing nose.
In a pre-op appointment, Caselli said Sturm told her that the previous surgeon had 'removed all the cartilage' from her nose, leaving it without proper support. (It is extremely unusual for surgeons to remove all the cartilage from a patient's nose).
Sturm suggested extracting some cartilage from the top of Caselli's right ear and implanting it into her nose to help with the breathing issue, Caselli said.
Caselli agreed, saying she was won over by the chance to be operated on by a female surgeon and Sturm's apparent personable and kind nature.
Lindsay Sturm, who carried out the procedure, is pictured above. According to Caselli, the cosmetic surgeon said that in Caselli's previous nose job all the cartilage was removed from her nose
Just before the surgery in 2021, the pair prayed together for a successful procedure and a good outcome.
Caselli said after the surgery she had to wear a nose bandage and splint, a plastic device placed outside the nose after surgery to support its new shape, for about two weeks but, even with the swelling from surgery, became concerned about her nose every time she removed a bandage to wash it.
'I actually voiced my concerns because I did see some issues,' she said. 'One side of my nose that I wanted changed originally, that was still the same, and the side that was a little swollen didn't look right.
'I was also concerned because in the profile view of the side of my face, it looked different, the tip of my nose was missing, well, it didn't have a tip.'
She said Sturm initially told her that the appearance could be linked to the swelling from surgery but then retorted that she shouldn't ask for a perfect nose because no one's nose is perfect.
'I was shocked by that,' Caselli said. 'I told her that I am not trying to achieve the perfect nose, I just want a functioning nose that looks nice and normal, but this doesn't. It looks normal it looks very messed up.
'She tried to make me feel bad for that.'
Caselli also said that at one point a hole opened up in the middle of her nose after a suture came loose following the surgery.
During the procedure, Sturm was also meant to perform liposuction on the bottom of Caselli's chin, but Caselli said that this wasn't done properly, with the area she wanted removed 'still there' when she woke up from surgery.
Caselli is a social mom who loves to go out with friends
But her nose is a constant worry
Sturm offered to do a fat transfer to Caselli's nose after the surgery, Caselli said, but she refused, and says she's now seeking help from a new surgeon.
Caselli also claimed that her breathing is now 'much worse' than before, with now having to breathe through her mouth most of the time.
She said she holds up the end of her nose sometimes when she runs to get air in and is also waking up throughout the night, suffering from a dry mouth and breathing issues.
'I hope revealing this helps people,' she said. 'The irony here is that she was an expert and she still messed up my nose. Everyone should know the difference between a cosmetic surgeon and a plastic surgeon.
'I am lucky, but unlucky, people go through worse things, terrible things, but they can cover their bodies. For me, I can't cover my face.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Woman's face melted off after Bath & Body Works candle explodes, lawsuit claims
Woman's face melted off after Bath & Body Works candle explodes, lawsuit claims

Daily Mail​

time13 minutes ago

  • Daily Mail​

Woman's face melted off after Bath & Body Works candle explodes, lawsuit claims

A former New York City city hall worker has sued Bath & Body Works after she claimed a candle exploded in her face, leaving her with severe burns and scars. Renita Francois, 41, of Valley Stream, Long Island, leaned in to take a whiff of her Sweater Weather candle when it exploded in her face on January 19, 2023, a federal lawsuit filed earlier this month claimed. Within moments of lighting the $27 three-wick candle, which is manufactured by Premier Candle Corporation, it exploded, sending glass, molten wax, and flames into her face. The explosion caused her eyelashes and eyebrows to sear off,. Agonizing photos show her her forehead, cheeks, and lips covered in burns and raw blisters. 'Her face was nearly unrecognizable,' the lawsuit said. Her arms also sustained permanent dark spots where wax landed. 'The wax continued to burn as it hardened, refusing to cool,' the complaint read. Her husband, McEvans Francois, desperately tried to help the mother-of-two by running her wounds under water to help cool the wax, but the 'damage had already been done,' the filing states. The candle, which was sitting on her dresser, was left charred black, deformed, and with holes in it. The former Mayor Bill de Blasio employee was rushed to the hospital, where she was diagnosed with second-degree burns. The ordeal shook her confidence and left the once 'unshakeable' public servant 'fractured,' the complaint read. 'Renita has always been the life of the party, the connector, the woman who makes things happen,' it read. 'She was the only who brought people together, whether for family celebrations, professional networking events, or impromptu gatherings just for the joy of it. 'Now, she finds herself forced to navigate sympathy, unwanted stares, and intrusive questions about her injuries rather than the work she is there to champion... Now, she hesitates before stepping into social settings.' Her young children even ask her: 'Mommy, what happened to your face?' and 'Are you going to be okay?' Her lawyer, Tyrone Blackburn, said in the complaint that those questions 'cut deeper than burns ever could.' Francois argued the tragedy was preventable as the company knew its three-wick candles were dangerous and had 'prior knowledge' that the product 'posed a serious and foreseeable risk of explosion.' The lawsuit claimed the home products company knew they were selling 'defective candles without adequate warnings, proper testing, or necessary product modification to prevent catastrophic failures.' Premier Candle Corporation, which is headquartered in Canada, does not have to follow US law and didn't have to undergo the 'rigorous standards required' by America, the lawsuit alleged. 'There is no automatic recall process for candles exhibiting hazardous burn behavior,' the lawsuit read. 'The US enforces mandatory recalls and imposes legal penalties for noncompliance.' She is asking for compensatory and punitive damages, for the candle to be recalled, and for her attorney fees to be covered, among others. She is also requesting a jury trial. Francois worked as an executive director of de Blasio's Mayor's Action Plan for Neighborhood Safety from July 2018 to April 2022. She often spoke publicly in the role. Daily Mail has contacted Bath & Body Works, Premier Candles, Francois and her lawyer for comment.

Pope Leo declares his first miracle after claiming divine intervention saved newborn in Rhode Island
Pope Leo declares his first miracle after claiming divine intervention saved newborn in Rhode Island

Daily Mail​

time2 hours ago

  • Daily Mail​

Pope Leo declares his first miracle after claiming divine intervention saved newborn in Rhode Island

Pope Leo XIV has officially declared his first miracle as pontiff, crediting the 2007 recovery of a dying newborn in Rhode Island to divine intervention following a physician's desperate prayer. The Vatican announced this week that the ailing child, Tyquan Hall, who was born prematurely via emergency cesarean section and left with no detectable pulse, made a full recovery after a doctor invoked the name of a long-forgotten 19th-century Spanish priest. The declaration elevates not just a miraculous story of life snatched from the jaws of death but also the potential sainthood of the humble cleric whose name was called in a moment of need. Reverend Timothy Reilly of the Diocese of Providence said: 'We are thrilled that this recognition will move the cause of beatification and canonization forward for Venerable Servant of God Salvador Valera Parra.' The miracle marks the first to be authenticated under Pope Leo XIV and it may set in motion the canonization of Father Valera Parra, a priest who died in Spain in 1889 and had no known miracles to his name, until now. According to the Diocese of Almeria, Dr Juan Sanchez, a Spanish-born physician working in a Rhode Island hospital in 2007, found himself verging on despair. Baby Tyquan had been born in critical condition - pale, turning blue and without a heartbeat, suffering from oxygen deprivation so severe that death, or permanent brain damage, seemed all but certain. With no medical options left, Sanchez offered a prayer, not to a modern saint or well-known figure, but to Valera Parra, the patron of his hometown of Huercal-Overa in southeastern Spain. What happened next, according to hospital staff and the Vatican, was immediate and inexplicable. WJAR-TV reported: 'A few minutes after the faithful prayer, the child's heart began to beat normally without medical intervention.' Doctors braced for the child to have severe neurological damage, but Tyquan defied every expectation. He spoke at 18 months, walked at two years, and today, shows no sign of impairment - a living testament, the Vatican says, to the power of faith. The miracle is especially striking as Valera Parra had never visited the United States, let alone New England. Rev Reilly said: 'The cool thing is, the more you think about the miracle itself, Father Valera lived in the 19th century. He never came to the U.S. Never came to Rhode Island. 'And yet… the doctor called out and called upon his name… he decided to intervene.' Born in 1816 and known as a simple diocesan priest, Valera Parra died in 1889 without fame, controversy, or claims of supernatural gifts. But the miracle attributed to his name now places him squarely on the path to sainthood, requiring only one more confirmed miracle for canonization. The miracle declaration also makes history for Pope Leo XIV, the first American and first Peruvian citizen to lead the Church. Born Robert Prevost in Chicago, Leo, 69, was elected pope on May 8, following the death of Pope Francis. A former missionary in Peru, he later oversaw the Vatican's powerful office of bishops before ascending to the papacy. Known for his calm intellect, deep spirituality, and surprising relatability, Leo is as comfortable quoting Scripture as he is solving Wordle puzzles with his brother back in Illinois. He's also a White Sox fan and has also said he will not not giving up playing tennis anytime soon. This week's announcement also signals Leo XIV's broader vision for sainthood in the modern era. Alongside Valera Parra's miracle, the Vatican is advancing the cause of Carlos Acutis, a British-born Millennial teen who died of leukemia in 2007 and whose body remains incorrupt in a glass tomb in Assisi, Italy. Carlos, known for creating a website cataloging Eucharistic miracles, is on track to become the first Millennial saint.

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths

The Independent

time3 hours ago

  • The Independent

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the death of a third patient receiving one of its treatments for muscular dystrophy. The highly unusual move is a latest in a string of events that have hammered the company's stock for weeks and recently forced it to lay off 500 employees. The company's decision not to comply with the FDA also places future availability of its leading therapy, called Elevidys, in doubt. The FDA said in a statement Friday night that officials met with Sarepta and requested it suspend all sales but 'the company refused to do so.' The agency has the authority to pull drugs from the market, but the cumbersome regulatory process can take months or even years. Instead, the agency usually makes an informal request and companies almost always comply. 'We believe in access to drugs for unmet medical needs but are not afraid to take immediate action when a serious safety signal emerges,' FDA Commissioner Marty Makary said in a statement. Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects males, though it has faced scrutiny since its clearance in 2023. The one-time treatment received accelerated approval against the recommendations of some FDA scientists who doubted its effectiveness. The FDA granted full approval last year and expanded the therapy's use to patients 4 years and older, including those who can no longer walk. Previously, it was only available for younger patients who were still walking. Sarepta said Friday that its scientific review showed 'no new or changed safety signals' for younger patients with Duchenne's who have earlier stages of the disease. The company said it plans to keep the drug available for those patients. 'We look forward to continued discussions and sharing of information with FDA,' the company said in a statement. Sarepta halted shipments last month of the therapy for older boys with Duchenne's, which gradually destroys muscle and skeletal strength, resulting in early death. The move followed the deaths of two teenage boys taking the therapy. The company also confirmed a third death Friday: a 51-year-old patient who was taking an experimental gene therapy in a trial for a different form of muscular dystrophy. Sarepta said it reported the death to the FDA on June 20. The FDA said Friday it placed that trial on hold. Sarepta noted that the gene therapy involved in the incident uses 'a different dose and is manufactured using a different process,' than Elevidys. All three patient deaths were linked to liver injury, a side effect noted in Sarepta's prescribing information. Earlier this week Sarepta announced it would add a bold warning to drug and lay off a third of its employees. The company did not mention the third patient death in its news release or conference call announcing those changes, sparking pointed criticism from Wall Street analysts. Company shares fell more than 35% Friday to close at $14.07. Cambridge, Massachusetts-based Sarepta has received FDA approval for three other Duchenne's drugs since 2016, none of which have been confirmed to work. The company has long been criticized for failing to complete several studies needed to secure full FDA approval of its drugs. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store